[DISCLOSURE]
Hanmi Pharmaceutical (128940) reported on April 27 that its operating profit in the first quarter hiked 39.01 percent to 31.37 billion won (US$27.69 million) from the same period last year.
Its revenue fell 8.9 percent to 233.55 billion won and net profit 39.85 percent to 24.65 billion won on-year.
By Hwang You-mee (
theinvestor@heraldcorp.com)